Rohto Pharmaceutical Revenue

Rohto Pharmaceutical had revenue of 86.81B JPY in the quarter ending December 31, 2024, with 18.44% growth. This brings the company's revenue in the last twelve months to 295.57B, up 12.14% year-over-year. In the fiscal year ending March 31, 2024, Rohto Pharmaceutical had annual revenue of 270.84B with 13.48% growth.

Revenue (ttm)

295.57B

Revenue Growth

+12.14%

P/S Ratio

1.76

Revenue / Employee

40.72M

Employees

7,259

Market Cap

521.53B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	270.84B	32.18B	13.48%
Mar 31, 2023	238.66B	39.02B	19.54%
Mar 31, 2022	199.65B	18.36B	10.13%
Mar 31, 2021	181.29B	-7.04B	-3.74%
Mar 31, 2020	188.33B	4.75B	2.58%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Japan Tobacco	3,149.76B
Seven & i Holdings	10.34T
Ajinomoto Co.	1,522.62B
Kao Corporation	1,628.45B
Asahi Group Holdings	2,939.42B
Pan Pacific International Holdings	2,176.10B
Unicharm	988.98B
Kirin Holdings Company	2,338.39B

Revenue Rankings